12 October 2026 Argent BioPharma Advances Focused Immune Modulation and Inflammatory Disease Strategy Highlights: • Argent BioPharma consolidates its strategy around immune modulation and in?ammatory disease following the global licensing of CannEpil® • RGT-CA91980 established as the ...